NFE2L2 and glioblastoma: Nuclear factor-erythroid factor 2-related factor 2 (Nrf2) is an important transcription factor that plays a major role in GBM therapy by negatively impacting chemotherapy through activation of endogenous phase II detoxification mechanisms.